Current role of proton beam therapy in patients with hepatocellular carcinoma

키워드

참고문헌 (80)

1. Singal AG, "Epidemiology and surveillance for hepatocellular carcinoma: new trends", J Hepatol, 72, pp.250~261 (2020)
2. Bray F, "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 68, pp.394~424 (2018)
3. Fattovich G, "Hepatocellular carcinoma in cirrhosis:incidence and risk factors", Gastroenterology, 127(5 Suppl 1), pp.S35~S50 (2004)
4. El-Serag HB, "Hepatocellular carcinoma", N Engl J Med, 365, pp.1118~1127 (2011)
5. Zhang DY, "Fibrosis-dependent mechanisms of hepatocarcinogenesis", Hepatology, 56, pp.769~775 (2012)
6. Forner A, "Hepatocellular carcinoma", Lancet, 379, pp.1245~1255 (2012)
7. Sinn DH, "Comparison of clinical manifestations and outcomes between hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma: analysis of a nationwide cohort", PLoS One, 9, pp.e112184~ (2014)
8. Yu JI, "Radiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosis", World J Gastroenterol, 22, pp.6851~6863 (2016)
9. Bruix J, "Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial", J Hepatol, 57, pp.821~829 (2012)
10. Yang X, "Atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma", Lancet Oncol, 21, pp.e412~ (2020)
11. Korean Liver Cancer Association (KLCA) and National Cancer Center (NCC, "2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma", Gut and Liver, 13(3), pp.227~299 (2019), 거트앤리버 소화기연관학회협의회[DOI]
12. Dionisi F, "The use of proton therapy in the treatment of gastrointestinal cancers: liver", Cancer J, 20, pp.371~377 (2014)
13. Kalogeridi MA, "Role of radiotherapy in the management of hepatocellular carcinoma: a systematic review", World J Hepatol, 7, pp.101~112 (2015)
14. Klein J, "Hepatocellular carcinoma radiation therapy: review of evidence and future opportunities", Int J Radiat Oncol Biol Phys, 87, pp.22~32 (2013)
15. Cho JY, "The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma", Liver Int, 34, pp.795~801 (2014)
16. Corbin KS, "Extracranial oligometastases: a subset of metastases curable with stereotactic radiotherapy", J Clin Oncol, 31, pp.1384~1390 (2013)
17. 김상원, "Transcatheter arterial chemoembolization and radiation therapy for treatment-naïve patients with locally advanced hepatocellular carcinoma", Radiation oncology journal, 32(1), pp.14~22 (2014), 대한방사선종양학회
18. Yeung RH, "Proton beam therapy for hepatocellular carcinoma", Expert Rev Anticancer Ther, 17, pp.911~924 (2017)
19. Dionisi F, "Is there a role for proton therapy in the treatment of hepatocellular carcinoma? A systematic review", Radiother Oncol, 111, pp.1~10 (2014)
20. Lasley FD, "Treatment variables related to liver toxicity in patients with hepatocellular carcinoma, Child-Pugh class A and B enrolled in a phase 1-2 trial of stereotactic body radiation therapy", Pract Radiat Oncol, 5, pp.e443~e449 (2015)
21. Mizumoto M, "Evaluation of liver function after proton beam therapy for hepatocellular carcinoma", Int J Radiat Oncol Biol Phys, 82, pp.e529~e535 (2012)
22. Engelsman M, "Physics controversies in proton therapy", Semin Radiat Oncol, 23, pp.88~96 (2013)
23. Pursley J, "Dosimetric analysis and normal-tissue complication probability modeling of Child-Pugh score and albumin-bilirubin grade increase after hepatic irradiation", Int J Radiat Oncol Biol Phys, 107, pp.986~995 (2020)
24. Dawson LA, "Analysis of radiation-induced liver disease using the Lyman NTCP model", Int J Radiat Oncol Biol Phys, 53, pp.810~821 (2002)
25. Lawrence TS, "Hepatic toxicity resulting from cancer treatment", Int J Radiat Oncol Biol Phys, 31, pp.1237~1248 (1995)
26. Fukumitsu N, "Investigation of the geometric accuracy of proton beam irradiation in the liver", Int J Radiat Oncol Biol Phys, 82, pp.826~833 (2012)
27. Wang X, "Proton radiotherapy for liver tumors: dosimetric advantages over photon plans", Med Dosim, 33, pp.259~267 (2008)
28. Gandhi SJ, "Clinical decision tool for optimal delivery of liver stereotactic body radiation therapy: photons versus protons", Pract Radiat Oncol, 5, pp.209~218 (2015)
29. Mizumoto M, "Proton beam therapy for hepatocellular carcinoma: a comparison of three treatment protocols", Int J Radiat Oncol Biol Phys, 81, pp.1039~1045 (2011)
30. Alan Mitteer R, "Proton beam radiation induces DNA damage and cell apoptosis in glioma stem cells through reactive oxygen species", Sci Rep, 5, pp.13961~ (2015)
31. Paganetti H, "Relating proton treatments to photon treatments via the relative biological effectiveness-should we revise current clinical practice?", Int J Radiat Oncol Biol Phys, 91, pp.892~894 (2015)
32. Matsumoto Y, "Enhanced radiobiological effects at the distal end of a clinical proton beam: in vitro study", J Radiat Res, 55, pp.816~822 (2014)
33. 한영이, "Current status of proton therapy techniques for lung cancer", Radiation oncology journal, 37(4), pp.232~248 (2019), 대한방사선종양학회
34. 정광주, "The first private-hospital based proton therapy center in Korea; status of the Proton Therapy Center at Samsung Medical Center", Radiation oncology journal, 33(4), pp.337~343 (2015), 대한방사선종양학회
35. Yoo GS, "Comparison of clinical outcomes between passive scattering versus pencil-beam scanning proton beam therapy for hepatocellular carcinoma", Radiother Oncol, 146, pp.187~193 (2020)
36. Zhang Y, "A statistical comparison of motion mitigation performances and robustness of various pencil beam scanned proton systems for liver tumour treatments", Radiother Oncol, 128, pp.182~188 (2018)
37. Hata M, "Proton irradiation in a single fraction for hepatocellular carcinoma patients with uncontrollable ascites. Technical considerations and results", Strahlenther Onkol, 183, pp.411~416 (2007)
38. Hong TS, "A prospective feasibility study of respiratory-gated proton beam therapy for liver tumors", Pract Radiat Oncol, 4, pp.316~322 (2014)
39. 유정일, "Initial clinical outcomes of proton beam radiotherapy for hepatocellular carcinoma", Radiation oncology journal, 36(1), pp.25~34 (2018), 대한방사선종양학회
40. Habermehl D, "Evaluation of different fiducial markers for image-guided radiotherapy and particle therapy", J Radiat Res, 54(Suppl 1), pp.i61~i68 (2013)
41. Mizumoto M, "Proton beam therapy for hepatocellular carcinoma adjacent to the porta hepatis", Int J Radiat Oncol Biol Phys, 71, pp.462~467 (2008)
42. Fukumitsu N, "A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma", Int J Radiat Oncol Biol Phys, 74, pp.831~836 (2009)
43. Nakayama H, "Proton beam therapy for hepatocellular carcinoma: the University of Tsukuba experience", Cancer, 115, pp.5499~5506 (2009)
44. Nakayama H, "Proton beam therapy for hepatocellular carcinoma located adjacent to the alimentary tract", Int J Radiat Oncol Biol Phys, 80, pp.992~995 (2011)
45. Bush DA, "The safety and efficacy of high-dose proton beam radiotherapy for hepatocellular carcinoma: a phase 2 prospective trial", Cancer, 117, pp.3053~3059 (2011)
46. Bush DA, "Randomized clinical trial comparing proton beam radiation therapy with transarterial chemoembolization for hepatocellular carcinoma : results of an interim analysis", Int J Radiat Oncol Biol Phys, 95, pp.477~482 (2016)
47. Hong TS, "Multi-institutional phase II study of high-dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic cholangiocarcinoma", J Clin Oncol, 34, pp.460~468 (2016)
48. 김태현, "Phase I Dose-Escalation Study of Proton Beam Therapy for Inoperable Hepatocellular Carcinoma", Cancer Research and Treatment, 47(1), pp.34~45 (2015), 대한암학회[DOI]
49. Kim TH, "Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: a randomized phase III trial", J Hepatol, 74, pp.603~612 (2021)
50. Ohara K, "Radiation tolerance of cirrhotic livers in relation to the preserved functional capacity: analysis of patients with hepatocellular carcinoma treated by focused proton beam radiotherapy", Int J Radiat Oncol Biol Phys, 38, pp.367~372 (1997)
51. Hata M, "Proton beam therapy for hepatocellular carcinoma patients with severe cirrhosis", Strahlenther Onkol, 182, pp.713~720 (2006)
52. Hashimoto T, "Repeated proton beam therapy for hepatocellular carcinoma", Int J Radiat Oncol Biol Phys, 65, pp.196~202 (2006)
53. Yoo GS, "Do biliary complications after proton beam therapy for perihilar hepatocellular carcinoma matter?", Cancers (Basel), 12, pp.2395~ (2020)
54. Vilana R, "Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma", Hepatology, 16, pp.353~357 (1992)
55. Livraghi T, "Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions", Radiology, 214, pp.761~768 (2000)
56. Haug CE, "Liver transplantation for primary hepatic cancer", Transplantation, 53, pp.376~382 (1992)
57. Noguchi T, "Clinicopathologic factors influencing the long-term prognosis following hepatic resection for large hepatocellular carcinoma more than 10 cm in diameter", Semin Oncol, 24(2 Suppl 6), pp.S6-7~S6-13 (1997)
58. Poon RT, "Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter", J Am Coll Surg, 194, pp.592~602 (2002)
59. Pandey D, "Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection", Ann Surg Oncol, 14, pp.2817~2823 (2007)
60. McGinn CJ, "Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model", J Clin Oncol, 16, pp.2246~2252 (1998)
61. Hawkins MA, "Radiation therapy for hepatocellular carcinoma: from palliation to cure", Cancer, 106, pp.1653~1663 (2006)
62. Sugahara S, "Proton beam therapy for large hepatocellular carcinoma", Int J Radiat Oncol Biol Phys, 76, pp.460~466 (2010)
63. Mohan R, "Radiobiological issues in proton therapy", Acta Oncol, 56, pp.1367~1373 (2017)
64. Jihye Kim, "Radiation-induced Myositis after Proton Beam Therapy to Huge Hepatocellular Carcinoma", Journal of Liver Cancer, 19(2), pp.136~142 (2019), 대한간암학회[DOI]
65. Yeung R, "Chest wall toxicity after hypofractionated proton beam therapy for liver malignancies", Pract Radiat Oncol, 8, pp.287~293 (2018)
66. Smitaman E, "MR imaging of atraumatic muscle disorders", Radiographics, 38, pp.500~522 (2018)
67. Swanick CW, "Incidence and predictors of chest wall toxicity after high-dose radiation therapy in 15 fractions", Pract Radiat Oncol, 7, pp.63~71 (2017)
68. Kanemoto A, "Dose-volume histogram analysis for risk factors of radiation-induced rib fracture after hypofractionated proton beam therapy for hepatocellular carcinoma", Acta Oncol, 52, pp.538~544 (2013)
69. Chen LS, "Prevalence of gastric ulcer in cirrhotic patients and its relation to portal hypertension", J Gastroenterol Hepatol, 11, pp.59~64 (1996)
70. Kitano S, "Does portal hypertension contribute to the pathogenesis of gastric ulcer associated with liver cirrhosis?", J Gastroenterol, 35, pp.79~86 (2000)
71. Indelicato DJ, "Incidence and dosimetric parameters of pediatric brainstem toxicity following proton therapy", Acta Oncol, 53, pp.1298~1304 (2014)
72. Giantsoudi D, "Incidence of CNS injury for a cohort of 111 patients treated with proton therapy for medulloblastoma:LET and RBE associations for areas of injury", Int J Radiat Oncol Biol Phys, 95, pp.287~296 (2016)
73. Kim TH, "Does risk-adapted proton beam therapy have a role as a complementary or alternative therapeutic option for hepatocellular carcinoma?", Cancers (Basel), 11, pp.230~ (2019)
74. Choi C, "Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma", World J Gastroenterol, 25, pp.2416~2429 (2019)
75. Gyu Sang Yoo, "Radiation-induced abscopal effect and its enhancement by programmed cell death 1 blockade in the hepatocellular carcinoma: A murine model study", Clinical and Molecular Hepatology, 27(1), pp.144~156 (2021), 대한간학회[DOI]
76. Yu JI, "Clinical significance of radiotherapy before and", or during nivolumab treatment in hepatocellular carcinoma, 2019, pp.8, 6986~6994
77. Kim N, "Proton beam therapy reduces the risk of severe radiation-induced lymphopenia during chemoradiotherapy for locally advanced non-small cell lung cancer: a comparative analysis of proton versus photon therapy", Radiother Oncol, 156, pp.166~173 (2021)
78. Cho Y, "Impact of treatmentrelated lymphopenia on immunotherapy for advanced non-small cell lung cancer", Int J Radiat Oncol Biol Phys, 105, pp.1065~1073 (2019)
79. Lievens Y, "Defining oligometastatic disease from a radiation oncology perspective: an ESTROASTRO consensus document", Radiother Oncol, 148, pp.157~166 (2020)
80. Aibe N, "Multi-institutional retrospective analysis of the outcomes of proton beam therapy for patients with 1 to 3 pulmonary oligometastases from various primary cancers", Adv Radiat Oncol, 6, pp.100690~ (2021)

관련 논문AI추천